Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From David Filmore
A snapshot of medical device approvals captured in Medtech Insight's Approvals Tracker. A muscle stimulation device to treat urinary incontinence passed US FDA's review, while a peripheral artery stent with a new delivery system gained European sign off.
On this week's podcast, David Filmore and Ferdous Al-Faruque discuss the results of this week's midterm elections in the US and what it could mean for the medtech sector.
The balance of power will be shifting in Washington, DC, following the Nov. 6 US midterm elections, but that probably will not mean major changes for medtech policies. Here are some key takeaways from the election for device and diagnostics companies.
Troubling stories about US FDA inspections captured the attention of Medtech Insight readers last month. Other noteworthy US regulatory and policy themes from October: efforts to improve device reimbursement, salary trends, and a medtech focus in Congress.
A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. Two devices to help surgeons performing thyroid surgery made the list, as did several devices in the diabetes space.
As digital health rapidly expands its footprint, Cognizant's Vyom Bhuta says medical device companies need to evolve with the changing health-care landscape by making better use of the vast troves of available device data to improve products and patient lives.